Hyperthyroidism is a popular thyroid disorder instead of Hypothyroidisim. It affects mostly to the women aged between 20 to 40 years with a condition by overactive thyroid gland.
This disorder can go further for certain disease such as as Grave's disease. It affects the immune system of the sufferer to be autoimmune disease where the system attack their thyroid gland and stimulate it to poduce excessive amount of two thyroid hormones. Though the mechanism remained unclear and has been hypothesized as genetical factor, this disease often found related to family hisotry.
Signs and symptoms of this thyroid disorder may include:
- Feeling warm
- Weakness and fatigue
- Increased perspiration
- Accelerated heartbeat
- Trembling hands
- Weight loss
- Irritability / anxiety
- Loose or frequent stools
- Menstrual changes
- Eye problems - such as irritation and general discomfort
- Infertility
Other further disease risk is Hashimoto’s disease.
Like Graves’ disease, Hashimoto’s disease also affects the immune system of the patient become autoimmune disease causing their own immune attact their thyroid gland.
In addition to common symptoms of thyroid disorders, Hashimoto’s disease can lead to goiter, depression, heart problems, and birth defects.
The signs and symptoms of this disease includes:
- Fatigue
- Depression
- Sluggishness
- Sensation of feeling cold
- Weight gain of 5–10 pounds
- Dry hair and skin
- Constipation, less frequent bowel movements
- Menstrual changes
Other type of thyroid disorders is thyroid nodules. It's characterized by a lump or swelling in the thyroid gland. While the vast majority of thyroid nodules are very small, and often unnoticeable by sufferers, thyroid nodules can grow to readily detectable, ranging from a half inch (or one centimeter) to several inches across.
Thyroid nodules are not caused by an underactive thyroid or overactive thyroid. Often they project no real physical symptoms, and are either only detected incidentally during a physical examination or brought to attention when they begin to present pain in the neck or affect normal swallowing and/or breathing.
While the vast majority of thyroid nodules are benign, the possibility of malignancy or cancerous cells in the nodule is always a concern when abnormally large thyroid nodules are discovered.
Homeopathic and Natural Medicine Treatment
Archives Label
acai berry
Blood Pressure
Breast Enhancement
Cellulite
cholesterol
Colon Cleansing
croton oil
graves disease
hashimoto disease
HCA
HDL
hydrocitric acid
hyperthyroidism
LDL
levels of blood pressure
levels of cholesterol
lose weight fast
Menopause
natural treatment for blood pressure
natural treatment for cholesterol
overactive thyroid
Prostate
prostate cancer
sleep apnea
sleep disorders
snooring
Stress and Depression
thyroid
thyroid cancer
thyroid disorders
weight loss
Monday, December 7, 2009
Thyroid Cancer
What is Thyroid cancer?
Thyroid Cancer is the cancer that occur in thyroid gland.
The diagram of our thyroids as following;
Thyroid cancer can spread into nearby tissues and other parts of the body.
Most common thyroid cancers are:
1. Papillary Carcinoma
2. Follicular Carcinoma and Hurtle Cell Carcinoma (subtype of follicular carcinoma)
3. Medullary Thyroid Carcinoma
4. Anaplastic Carcinoma
5. Thyroid Lymphoma
6. Parathyroid Cancer
Papillary Carcinoma
Papillary carcinoma is thyroid cancer that typically grow very slowly.
Usually they develop in only one lobe of the thyroid gland, but sometimes they occur in both lobes.
Even though they grow slowly, papillary carcinoma often spread to the lymph nodes in the neck. But, most of the time, this can be succesfully treated and is rarely fatal.
Follicullar Carcinoma
Follicular carcinoma is the next most common type of thyroid cancer.
It is also sometimes called follicular cancer or follicular adenocarcinoma.
Follicular cancer is much less common than papillary thyroid cancer, making up about 1 of 10 thyroid cancers.
It is more common in countries where people don't get enough iodine in their diet.
These cancers usually remain in the thyroid gland.
Unlike papillary carcinoma, follicular carcinomas usually don't spread to lymph nodes, but some can spread to other parts of the body, such as the lungs or bones.
The prognosis for follicular carcinomas is probably not quite as good as that of papillary carcinoma, although it is still very good in most cases.
Hurthle Cell Carcinoma
Hurthle cell carcinoma also known as oxyphil cell carcinoma. It is actually a kind of follicular carcinoma.
This type accounts for about 4% of thyroid cancers.
The prognosis may not be as good as that of typical follicular carcinoma because this subtype is harder to find and treat as it is less likely to absorb radioactive iodine.
Radioactive iodine is used for treatment and to find metastases of differentiated thyroid cancer.
Medullary Thyroid Carcinoma
Medullary thyroid carcinoma accounts for about 5% of thyroid cancers.
It develops from the C cells of the thyroid gland.
Sometimes this cancer can spread to lymph nodes, the lungs, or liver even before a thyroid nodule is discovered.
These cancers usually make calcitonin and carcinoembryonic antigen (CEA), which can be found by blood tests.
Calcitonin is a hormone that helps control the amount of calcium in blood.
CEA is a protein made by certain cancers, such as colorectal cancer and MTC. Because medullary cancer does not absorb or take up radioactive iodine (used for treatment and to find metastases of differentiated thyroid cancer), the prognosis (outlook) is not quite as good as that for differentiated thyroid cancers.
There are 2 types of MTC.
The first type, occurring in about 8 of 10 cases, is called sporadic MTC.
Sporadic MTC is not inherited; that is, it does not run in families. It occurs mostly in older adults and in only 1 thyroid lobe.
The other type of MTC is inherited and can occur in each generation of a family.
These familial MTC often develop during childhood or early adulthood and can spread early. Patients usually have cancer in both thyroid lobes and in several areas of each lobe. They are often linked with an increased risk of other types of tumors.
Anaplastic Carcinoma
Anaplastic carcinoma (also called undifferentiated carcinoma) is a rare form of thyroid cancer, making up about 2% of all thyroid cancers.
It is thought to sometimes develop from an existing papillary or follicular cancer.
This cancer is called undifferentiated because the cancer cells do not look very much like normal thyroid tissue cells under the microscope.
This is an aggressive cancer that rapidly invades the neck, often spreads to other parts of the body, and is very hard to treat.
Thyroid Lymphoma
Lymphoma is very uncommon in the thyroid gland.
Lymphomas are cancers that develop from lymphocytes, the main cell type of the immune system.
Most lymphocytes are found in lymph nodes, which are pea-sized collections of immune cells scattered throughout the body (including the thyroid gland).
Thyroid Sarcoma
These rare cancers start in the supporting cells of the thyroid.
They are often aggressive and hard to treat.
Parathyroid Cancer
Behind, but attached to, the thyroid gland are 4 tiny glands called the parathyroids.
The parathyroid glands help regulate the body's calcium levels.
Cancers of the parathyroid glands are very rare; there are probably fewer than 100 cases each year in the United States.
Parathyroid cancers cause the blood calcium level to be elevated. This causes a person to become tired, weak, and drowsy.
High calcium also makes you urinate (pee) a lot causing dehydration, which can make the weakness and drowsiness worse.
Other symptoms include bone pain and fractures, pain from kidney stones, depression, and constipation.
Larger parathyroid cancers may also be detected as a nodule near the thyroid.
No matter how large the nodule is, the only treatment is to remove it surgically.
Unfortunately, parathyroid cancer is much harder to cure than thyroid cancer.
Thyroid Cancer is the cancer that occur in thyroid gland.
The diagram of our thyroids as following;
Thyroid cancer can spread into nearby tissues and other parts of the body.
Most common thyroid cancers are:
1. Papillary Carcinoma
2. Follicular Carcinoma and Hurtle Cell Carcinoma (subtype of follicular carcinoma)
3. Medullary Thyroid Carcinoma
4. Anaplastic Carcinoma
5. Thyroid Lymphoma
6. Parathyroid Cancer
Papillary Carcinoma
Papillary carcinoma is thyroid cancer that typically grow very slowly.
Usually they develop in only one lobe of the thyroid gland, but sometimes they occur in both lobes.
Even though they grow slowly, papillary carcinoma often spread to the lymph nodes in the neck. But, most of the time, this can be succesfully treated and is rarely fatal.
Follicullar Carcinoma
Follicular carcinoma is the next most common type of thyroid cancer.
It is also sometimes called follicular cancer or follicular adenocarcinoma.
Follicular cancer is much less common than papillary thyroid cancer, making up about 1 of 10 thyroid cancers.
It is more common in countries where people don't get enough iodine in their diet.
These cancers usually remain in the thyroid gland.
Unlike papillary carcinoma, follicular carcinomas usually don't spread to lymph nodes, but some can spread to other parts of the body, such as the lungs or bones.
The prognosis for follicular carcinomas is probably not quite as good as that of papillary carcinoma, although it is still very good in most cases.
Hurthle Cell Carcinoma
Hurthle cell carcinoma also known as oxyphil cell carcinoma. It is actually a kind of follicular carcinoma.
This type accounts for about 4% of thyroid cancers.
The prognosis may not be as good as that of typical follicular carcinoma because this subtype is harder to find and treat as it is less likely to absorb radioactive iodine.
Radioactive iodine is used for treatment and to find metastases of differentiated thyroid cancer.
Medullary Thyroid Carcinoma
Medullary thyroid carcinoma accounts for about 5% of thyroid cancers.
It develops from the C cells of the thyroid gland.
Sometimes this cancer can spread to lymph nodes, the lungs, or liver even before a thyroid nodule is discovered.
These cancers usually make calcitonin and carcinoembryonic antigen (CEA), which can be found by blood tests.
Calcitonin is a hormone that helps control the amount of calcium in blood.
CEA is a protein made by certain cancers, such as colorectal cancer and MTC. Because medullary cancer does not absorb or take up radioactive iodine (used for treatment and to find metastases of differentiated thyroid cancer), the prognosis (outlook) is not quite as good as that for differentiated thyroid cancers.
There are 2 types of MTC.
The first type, occurring in about 8 of 10 cases, is called sporadic MTC.
Sporadic MTC is not inherited; that is, it does not run in families. It occurs mostly in older adults and in only 1 thyroid lobe.
The other type of MTC is inherited and can occur in each generation of a family.
These familial MTC often develop during childhood or early adulthood and can spread early. Patients usually have cancer in both thyroid lobes and in several areas of each lobe. They are often linked with an increased risk of other types of tumors.
Anaplastic Carcinoma
Anaplastic carcinoma (also called undifferentiated carcinoma) is a rare form of thyroid cancer, making up about 2% of all thyroid cancers.
It is thought to sometimes develop from an existing papillary or follicular cancer.
This cancer is called undifferentiated because the cancer cells do not look very much like normal thyroid tissue cells under the microscope.
This is an aggressive cancer that rapidly invades the neck, often spreads to other parts of the body, and is very hard to treat.
Thyroid Lymphoma
Lymphoma is very uncommon in the thyroid gland.
Lymphomas are cancers that develop from lymphocytes, the main cell type of the immune system.
Most lymphocytes are found in lymph nodes, which are pea-sized collections of immune cells scattered throughout the body (including the thyroid gland).
Thyroid Sarcoma
These rare cancers start in the supporting cells of the thyroid.
They are often aggressive and hard to treat.
Parathyroid Cancer
Behind, but attached to, the thyroid gland are 4 tiny glands called the parathyroids.
The parathyroid glands help regulate the body's calcium levels.
Cancers of the parathyroid glands are very rare; there are probably fewer than 100 cases each year in the United States.
Parathyroid cancers cause the blood calcium level to be elevated. This causes a person to become tired, weak, and drowsy.
High calcium also makes you urinate (pee) a lot causing dehydration, which can make the weakness and drowsiness worse.
Other symptoms include bone pain and fractures, pain from kidney stones, depression, and constipation.
Larger parathyroid cancers may also be detected as a nodule near the thyroid.
No matter how large the nodule is, the only treatment is to remove it surgically.
Unfortunately, parathyroid cancer is much harder to cure than thyroid cancer.
Labels:
thyroid cancer
Wednesday, November 18, 2009
Acai Berry for Weight Loss
Acai berry contains active amino acids, particularly to hydroxycitric acid (HCA) that can help anyone to lose weight without diet restriction and regular exercise. This is because this amino acid can block carbohydrate becomes fats, increase metabolism to burn existing fats, and increase serotonin levels which can make you full longer. Because this amino acid has been studies by many researchers and clinically effective for weight loss therapy therefore, many supplements use it as their active ingredients including pharmaceutical industries in the synthetic form.
However, most of supplementations containing this amino acid only provide HCA concentrate below than fivety per cent and only few of them such as HCA Fit that provides greater than 50% of HCA concentration in single pill. Though lower concentrate does not lower the effectiveness, but those who want to see fast outcomes may need some time to see significant results.
Studies also found the safety profile of Acai berry extract, particularly with their HCA is almost safe for long-term effects. In fact, there is few studies that uses high doses of HCA of Acai berry extract and still found safe from any potential adverse effects.
This is great choice for those who want to lose weight fast and have no time to do regular exercise and hard to control their diets. The effects of HCA can be seen instantly (particularly with the appetite) and better metabolism within days, while start seeing a reduced some ponds in the second week.
However, most of supplementations containing this amino acid only provide HCA concentrate below than fivety per cent and only few of them such as HCA Fit that provides greater than 50% of HCA concentration in single pill. Though lower concentrate does not lower the effectiveness, but those who want to see fast outcomes may need some time to see significant results.
Studies also found the safety profile of Acai berry extract, particularly with their HCA is almost safe for long-term effects. In fact, there is few studies that uses high doses of HCA of Acai berry extract and still found safe from any potential adverse effects.
This is great choice for those who want to lose weight fast and have no time to do regular exercise and hard to control their diets. The effects of HCA can be seen instantly (particularly with the appetite) and better metabolism within days, while start seeing a reduced some ponds in the second week.
Labels:
acai berry,
HCA,
hydrocitric acid,
lose weight fast,
weight loss
Saturday, October 18, 2008
Worst Menopause Symptoms May Start in Brain
Study challenges old notion that menopause starts in the ovaries.
Some of the most unpleasant symptoms of menopause, such as hot flashes and night sweats, have long been believed to originate in the ovaries.
But new research challenges that assumption, and instead suggests that menopausal symptoms, at least in part, may begin in the brain.
That's because the hypothalamus and the pituitary gland stop reacting normally to estrogen in some women, suggesting they may have developed a reduced sensitivity to estrogen, researchers at the New Jersey Medical School report in the Dec. 22/29 issue of the Journal of the American Medical Association.
"This is an important new concept: Menopause doesn't just originate in the ovary, but also in the brain," said Laura Goldsmith, a professor of obstetrics and gynecology and women's health at the New Jersey Medical School of the University of Medicine and Dentistry of New Jersey.
These findings may lead the way to further research that will ultimately help doctors predict the type of menopausal transition a woman might have, and help to design non-estrogen medications that could help reduce symptoms that women experience as they enter this phase of life, said Dr. Gerson Weiss, chairman of obstetrics and gynecology and women's health at the New Jersey Medical School.
Menopause refers to the time when menstruation stops. A woman is not considered menopausal until she has not had a period for 12 consecutive months, according to the North American Menopausal Society. The time before menopause, which is often rife with symptoms due to hormonal fluctuations, is called perimenopause. During perimenopause, common symptoms include hot flashes, trouble sleeping, vaginal dryness, mood swings and irregular periods.
This study stemmed from research done for the Study of Women's Health Across the Nation (SWAN), which was funded by the National Institutes of Health, that examined women's' health as they approached menopause.
The SWAN study included more than 3,300 women between the ages of 42 and 52 at the start of the study. A subset group of 840 women provided daily urine samples, which were tested for hormone levels. The samples were collected daily for one full menstrual cycle or 50 days, whichever came first.
From that group, the researchers learned that 160 did not ovulate. After further analyzing the hormone levels from the non-ovulating women, the researchers discovered that these women fell into three distinct groups.
The first group had an increase in their levels of estrogen, and then had an appropriate surge of luteinizing hormone (LH) that should have triggered ovulation, but didn't. According to Weiss, this lack of response indicated a problem originating in the ovary.
In the second group, estrogen levels peaked, but there was no correlating surge in LH, which Weiss said should be triggered by the hypothalamus and pituitary gland responding to higher estrogen levels.
The third group had similar estrogen levels early in their cycles, but didn't have an increase in estrogen later as the first and second groups did. LH levels didn't surge, but were higher for most of the cycle than they were in the other groups.
According to Weiss, this is "clear evidence that the brain is not responding to hormones," suggesting the second and third groups showed different kinds of decreased sensitivity to estrogen in the brain.
The women in the third group were also the ones most likely to report symptoms, such as hot flashes and night sweats.
Goldsmith said the researchers hope to continue studying these women. She said they'd especially like to learn how the timing of menopause correlates with their findings. For example, the researchers would like to see if the women in the third group were, perhaps, further along in the menopausal process.
"It appears that what's going on in menopause isn't only ovarian," said Dr. Steven Goldstein, a professor of obstetrics and gynecology at New York University School of Medicine. "We thought the pituitary responded to lower levels of estrogen, but there may be a lack of sensitivity to estrogen in the hypothalamus and pituitary."
What's important for women to know, said Goldsmith, is that there are "real biochemical changes occurring during menopause." Researchers are beginning to understand how those changes start to occur, which is the first step in trying to come up with more effective treatments.
SOURCES: Gerson Weiss, M.D., professor and chairman, obstetrics and gynecology and women's health; Laura Goldsmith, Ph.D., professor, obstetrics and gynecology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark; Steven Goldstein, M.D., professor , obstetrics and gynecology, and obstetrician/gynecologist, New York University School of Medicine and Medical Center, New York City; Dec. 22/29, 2004, Journal of the American Medical Association.
Some of the most unpleasant symptoms of menopause, such as hot flashes and night sweats, have long been believed to originate in the ovaries.
But new research challenges that assumption, and instead suggests that menopausal symptoms, at least in part, may begin in the brain.
That's because the hypothalamus and the pituitary gland stop reacting normally to estrogen in some women, suggesting they may have developed a reduced sensitivity to estrogen, researchers at the New Jersey Medical School report in the Dec. 22/29 issue of the Journal of the American Medical Association.
"This is an important new concept: Menopause doesn't just originate in the ovary, but also in the brain," said Laura Goldsmith, a professor of obstetrics and gynecology and women's health at the New Jersey Medical School of the University of Medicine and Dentistry of New Jersey.
These findings may lead the way to further research that will ultimately help doctors predict the type of menopausal transition a woman might have, and help to design non-estrogen medications that could help reduce symptoms that women experience as they enter this phase of life, said Dr. Gerson Weiss, chairman of obstetrics and gynecology and women's health at the New Jersey Medical School.
Menopause refers to the time when menstruation stops. A woman is not considered menopausal until she has not had a period for 12 consecutive months, according to the North American Menopausal Society. The time before menopause, which is often rife with symptoms due to hormonal fluctuations, is called perimenopause. During perimenopause, common symptoms include hot flashes, trouble sleeping, vaginal dryness, mood swings and irregular periods.
This study stemmed from research done for the Study of Women's Health Across the Nation (SWAN), which was funded by the National Institutes of Health, that examined women's' health as they approached menopause.
The SWAN study included more than 3,300 women between the ages of 42 and 52 at the start of the study. A subset group of 840 women provided daily urine samples, which were tested for hormone levels. The samples were collected daily for one full menstrual cycle or 50 days, whichever came first.
From that group, the researchers learned that 160 did not ovulate. After further analyzing the hormone levels from the non-ovulating women, the researchers discovered that these women fell into three distinct groups.
The first group had an increase in their levels of estrogen, and then had an appropriate surge of luteinizing hormone (LH) that should have triggered ovulation, but didn't. According to Weiss, this lack of response indicated a problem originating in the ovary.
In the second group, estrogen levels peaked, but there was no correlating surge in LH, which Weiss said should be triggered by the hypothalamus and pituitary gland responding to higher estrogen levels.
The third group had similar estrogen levels early in their cycles, but didn't have an increase in estrogen later as the first and second groups did. LH levels didn't surge, but were higher for most of the cycle than they were in the other groups.
According to Weiss, this is "clear evidence that the brain is not responding to hormones," suggesting the second and third groups showed different kinds of decreased sensitivity to estrogen in the brain.
The women in the third group were also the ones most likely to report symptoms, such as hot flashes and night sweats.
Goldsmith said the researchers hope to continue studying these women. She said they'd especially like to learn how the timing of menopause correlates with their findings. For example, the researchers would like to see if the women in the third group were, perhaps, further along in the menopausal process.
"It appears that what's going on in menopause isn't only ovarian," said Dr. Steven Goldstein, a professor of obstetrics and gynecology at New York University School of Medicine. "We thought the pituitary responded to lower levels of estrogen, but there may be a lack of sensitivity to estrogen in the hypothalamus and pituitary."
What's important for women to know, said Goldsmith, is that there are "real biochemical changes occurring during menopause." Researchers are beginning to understand how those changes start to occur, which is the first step in trying to come up with more effective treatments.
SOURCES: Gerson Weiss, M.D., professor and chairman, obstetrics and gynecology and women's health; Laura Goldsmith, Ph.D., professor, obstetrics and gynecology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark; Steven Goldstein, M.D., professor , obstetrics and gynecology, and obstetrician/gynecologist, New York University School of Medicine and Medical Center, New York City; Dec. 22/29, 2004, Journal of the American Medical Association.
Labels:
Menopause
Croton Oil Fight Prostate Cancer
Croton Oil Fights Prostate Cancer
PISCATAWAY, N.J.
An active ingredient found in the oil of the Southeast Asian croton plant - 12-O-tetradecanoylphorbol-13-acetate, commonly known as TPA; may inhibit the growth of new prostate cancer cells, according to researchers at Rutgers University.
We demonstrated TPA could simultaneously stop the growth of new prostate cancer cells, kill existing cancer cells and ultimately shrink prostate tumors, said Allan Conney, Ph.D., one of the study's authors. The researchers also tested the effect of TPA in combination with all-trans retinoic acid (ATRA), a vitamin A derivative that has been shown to effectively treat leukemia.
Mice with induced prostate tumors received a daily dose of TPA, ATRA or a combination of the two for 46 days. After 21 days of treatment, tumor regression became apparent in 62 percent of mice treated with TPA, compared to 31 percent of mice treated with ATRA. All mice receiving the combination treatment showed signs of tumor regression. Researchers also found TPA and the combination treatment continued to inhibit tumor growth for the duration of the study, compared to ATRA inhibiting tumor growth only for the first 28 days of treatment.
Our studies are an important early step in a long process, and we are planning additional testing in humans, Conney said. Further research with these compounds and others could provide hope for the half million new cases of prostate cancer each year.
The study is published in the March issue of Cancer Research (64, 5:1811-20, 2004) ( cancerres.aacrjournals.org)
PISCATAWAY, N.J.
An active ingredient found in the oil of the Southeast Asian croton plant - 12-O-tetradecanoylphorbol-13-acetate, commonly known as TPA; may inhibit the growth of new prostate cancer cells, according to researchers at Rutgers University.
We demonstrated TPA could simultaneously stop the growth of new prostate cancer cells, kill existing cancer cells and ultimately shrink prostate tumors, said Allan Conney, Ph.D., one of the study's authors. The researchers also tested the effect of TPA in combination with all-trans retinoic acid (ATRA), a vitamin A derivative that has been shown to effectively treat leukemia.
Mice with induced prostate tumors received a daily dose of TPA, ATRA or a combination of the two for 46 days. After 21 days of treatment, tumor regression became apparent in 62 percent of mice treated with TPA, compared to 31 percent of mice treated with ATRA. All mice receiving the combination treatment showed signs of tumor regression. Researchers also found TPA and the combination treatment continued to inhibit tumor growth for the duration of the study, compared to ATRA inhibiting tumor growth only for the first 28 days of treatment.
Our studies are an important early step in a long process, and we are planning additional testing in humans, Conney said. Further research with these compounds and others could provide hope for the half million new cases of prostate cancer each year.
The study is published in the March issue of Cancer Research (64, 5:1811-20, 2004) ( cancerres.aacrjournals.org)
Labels:
croton oil,
Prostate,
prostate cancer
Friday, October 17, 2008
Hypothyroidism causes early menopause
Menopause can be a difficult time for many women.
Reductions in circulating estrogen hormone levels result in a number of physical and physiological changes, which in turn may lead to mental and emotional stress.
While short-term hormone replacement therapy helps many women, most symptoms of menopause can be relieved with the use of thyroid curing medicine that is thyromine.
Thyromine works very well for people who have 'hypothyroidism’ a key cause of early start of menopause.
All the ingredients of thyromine (For example L-Tyrosine, Guglipid, Adrenal Powder from Bovine, Piper Longum Extract and Ginger extract) work to stimulate the metabolism, bad cholesterol and increase good cholesterol help regulate body's stress levels, increase the production of thyroid hormones and stimulate the immune system.
Weight gain during menopause can be distressing.
Shifting to a low fat, high-fiber diet and controlling overall dietary intake can help control weight gain. Diets rich in phytoestrogens, or plant estrogens, may offer additional relief. But the linseed product like thyromine is also a good source of phytoestrogens.
Thyroid treatment system, for example Thyromine, work by stimulating the body to produce normal levels of thyroxine, because the supplements are all natural this may be done without side effects such headaches and insomnia.
The body is also provided with necessary nutrients that help it to function properly. Thyroid treatment supplements may also help to restore deficient iodine levels, as adequate amounts are vital to a healthy thyroid gland.
Many women suffer from irritability, mood swings, and depression during the onset of menopause. While some of this may be attributable to the stress of undergoing a major life change, any such symptoms should be carefully evaluated by a physician and appropriately managed. Depending on the severity of symptoms, thyromine dosages can be prescribed.
With a healthy diet and exercise, menopausal women can improve distressing symptoms such as weight gain and mood swings through the thyroid treatment. Many women experience a noticeable improvement in their overall physical condition within a few weeks of thyromine intake. Everyone tends to experience slightly different results due to individual body chemistry and composition.
Reductions in circulating estrogen hormone levels result in a number of physical and physiological changes, which in turn may lead to mental and emotional stress.
While short-term hormone replacement therapy helps many women, most symptoms of menopause can be relieved with the use of thyroid curing medicine that is thyromine.
Thyromine works very well for people who have 'hypothyroidism’ a key cause of early start of menopause.
All the ingredients of thyromine (For example L-Tyrosine, Guglipid, Adrenal Powder from Bovine, Piper Longum Extract and Ginger extract) work to stimulate the metabolism, bad cholesterol and increase good cholesterol help regulate body's stress levels, increase the production of thyroid hormones and stimulate the immune system.
Weight gain during menopause can be distressing.
Shifting to a low fat, high-fiber diet and controlling overall dietary intake can help control weight gain. Diets rich in phytoestrogens, or plant estrogens, may offer additional relief. But the linseed product like thyromine is also a good source of phytoestrogens.
Thyroid treatment system, for example Thyromine, work by stimulating the body to produce normal levels of thyroxine, because the supplements are all natural this may be done without side effects such headaches and insomnia.
The body is also provided with necessary nutrients that help it to function properly. Thyroid treatment supplements may also help to restore deficient iodine levels, as adequate amounts are vital to a healthy thyroid gland.
Many women suffer from irritability, mood swings, and depression during the onset of menopause. While some of this may be attributable to the stress of undergoing a major life change, any such symptoms should be carefully evaluated by a physician and appropriately managed. Depending on the severity of symptoms, thyromine dosages can be prescribed.
With a healthy diet and exercise, menopausal women can improve distressing symptoms such as weight gain and mood swings through the thyroid treatment. Many women experience a noticeable improvement in their overall physical condition within a few weeks of thyromine intake. Everyone tends to experience slightly different results due to individual body chemistry and composition.
Labels:
thyroid
Wednesday, October 15, 2008
Prostate cancer and natural treatment
Dietary changes should be on the prescription pads of doctors treating men with prostate cancer.
New research shows that eating more whole grains, vegetables, fruit, and legumes while eating less meat, dairy, and refined carbohydrates could slow the progression of the deadly disease.
Studies have associated the Western diet not only with prostate cancer incidence but also with a greater risk of disease progression after treatment, said Gordon A. Saxe, MD, PhD, lead author of the study and assistant professor of Family and Preventive Medicine at the Moores Cancer Center at the University of California, San Diego.
Conversely, many elements of plant-based diets have been associated with reduced risk of progression.
Prostate-specific antigen (PSA) is a marker for prostate cancer recurrence and often the earliest sign of spread of the disease beyond the prostate gland, even in people with no symptoms.
Saxe and colleagues conducted a six-month preliminary study to investigate whether a plant-based diet, reinforced with stress-management training, could prevent or lessen a rise in PSA among ten men with recurrent prostate cancer.
The men and their spouses or other support person participated in intensive group and individual diet and stress-reduction trainings.
The men were taught to shift their diet to more whole grains, vegetables, fruit, and legumes and to eat less meat, dairy, and refined carbohydrates (such as white rice, white flour, and sugar).
The people took cooking classes, participated in group discussions and meals, and were counseled regarding calorie intake (1,600 calories per day) and portion sizes.
Compared with the rate of PSA rise in the prestudy period, there was a significant reduction on the rate of rise throughout the intervention period.
Nine of the ten men had a slower progression of PSA levels.
Four of the ten men had a lower PSA level than when they started the diet.
The time it took the men's PSA levels to double increased nearly tenfold over six months, suggesting a strong protective effect.
Prostate cancer is the second most common cancer affecting men in the Western world after skin cancer.
About 35% of men who are treated for the disease will experience a recurrence within ten years. These men are at higher risk for life-threatening metastases.
Prevention of such recurrences is, therefore, an essential element of therapy. Unfortunately, the conventional treatments to prevent recurrence, such as hormone therapy, cause many undesirable side effects, such as hot flashes, loss of libido, and loss of bone mass.
These findings have significant therapeutic potential for recurrent prostate cancer, concluded Dr. Saxe. A natural dietary and lifestyle based approach may serve as an adjunct or alternative to hormonal therapy.
Prostacet as a natural treatment for prostate cancer provide lot of strong ingredient extract based on the expert research. You can see more detail how it works and what kind of ingredients they used in their site here.
Other mention should not ignored is general lifestyle. It is also contributes to the health of the prostate.
Exercise also promotes circulation and relieves tension in the body, which enhances the odds of a healthy prostate.
New research shows that eating more whole grains, vegetables, fruit, and legumes while eating less meat, dairy, and refined carbohydrates could slow the progression of the deadly disease.
Studies have associated the Western diet not only with prostate cancer incidence but also with a greater risk of disease progression after treatment, said Gordon A. Saxe, MD, PhD, lead author of the study and assistant professor of Family and Preventive Medicine at the Moores Cancer Center at the University of California, San Diego.
Conversely, many elements of plant-based diets have been associated with reduced risk of progression.
Prostate-specific antigen (PSA) is a marker for prostate cancer recurrence and often the earliest sign of spread of the disease beyond the prostate gland, even in people with no symptoms.
Saxe and colleagues conducted a six-month preliminary study to investigate whether a plant-based diet, reinforced with stress-management training, could prevent or lessen a rise in PSA among ten men with recurrent prostate cancer.
The men and their spouses or other support person participated in intensive group and individual diet and stress-reduction trainings.
The men were taught to shift their diet to more whole grains, vegetables, fruit, and legumes and to eat less meat, dairy, and refined carbohydrates (such as white rice, white flour, and sugar).
The people took cooking classes, participated in group discussions and meals, and were counseled regarding calorie intake (1,600 calories per day) and portion sizes.
Compared with the rate of PSA rise in the prestudy period, there was a significant reduction on the rate of rise throughout the intervention period.
Nine of the ten men had a slower progression of PSA levels.
Four of the ten men had a lower PSA level than when they started the diet.
The time it took the men's PSA levels to double increased nearly tenfold over six months, suggesting a strong protective effect.
Prostate cancer is the second most common cancer affecting men in the Western world after skin cancer.
About 35% of men who are treated for the disease will experience a recurrence within ten years. These men are at higher risk for life-threatening metastases.
Prevention of such recurrences is, therefore, an essential element of therapy. Unfortunately, the conventional treatments to prevent recurrence, such as hormone therapy, cause many undesirable side effects, such as hot flashes, loss of libido, and loss of bone mass.
These findings have significant therapeutic potential for recurrent prostate cancer, concluded Dr. Saxe. A natural dietary and lifestyle based approach may serve as an adjunct or alternative to hormonal therapy.
Prostacet as a natural treatment for prostate cancer provide lot of strong ingredient extract based on the expert research. You can see more detail how it works and what kind of ingredients they used in their site here.
Other mention should not ignored is general lifestyle. It is also contributes to the health of the prostate.
Exercise also promotes circulation and relieves tension in the body, which enhances the odds of a healthy prostate.
Labels:
Prostate
Subscribe to:
Posts (Atom)